Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sphenopalatine Ganglion Block for PDPH
NCT03430531Phase 2Terminated
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- May 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lidocaine 10% oropharyngeal spray in post-dural puncture headache (PDPH), sponsored by Penn State Health Milton S. Hershey Medical Center. Started May 2019; status: terminated.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT03430531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03430531.